EX-99.2 4 y85546exv99w2.txt CERTAIN SUPPLEMENTAL INFO NOT IN PRESS RELEASE Exhibit 99.2 MERCK & CO., INC. OTHER FINANCIAL DISCLOSURES FIRST QUARTER 2003 NET PRODUCT SALES DETAIL
1Q `03 vs. 1Q `02 -------------------------------------------------------------------------------------- TOTAL TOTAL U.S. U.S. Foreign Foreign PRODUCT % CHG $ % CHG $ % CHG $ ----------------------------------------------------------------------------------------------------------------------------------- AGGRASTAT -3% 23 -69% 3 46% 20 ARCOXIA * 11 N/M - * 11 CANCIDAS * 47 * 27 * 20 COZAAR / HYZAAR 52% 643 58% 297 46% 347 CRIXIVAN/STOCRIN 24% 84 82% 39 -3% 45 FOSAMAX 58% 812 53% 585 74% 228 INVANZ 48% 6 38% 5 * 1 MAXALT 14% 80 11% 60 26% 20 PRIMAXIN 36% 163 * 62 8% 102 PRINIVIL / PRINZIDE -82% 36 -88% 22 -21% 14 PROPECIA 37% 66 64% 36 14% 30 PROSCAR 20% 139 27% 64 14% 74 SINGULAIR 13% 474 3% 341 48% 132 TIMOPTIC/TIMOPTIC XE -6% 36 -67% 2 7% 34 TRUSOPT/COSOPT 24% 107 39% 46 14% 61 VASOTEC / VASERETIC -10% 168 N/M -4 0% 172 VIOXX -12% 527 -25% 318 20% 209 ZOCOR 7% 1,250 4% 713 13% 537 HEPATITIS VACCINES 63% 65 56% 55 * 10 VIRAL VACCINES 31% 118 28% 109 95% 8 OTHER VACCINES * 59 * 46 95% 12
* > 100% N/M - Not Meaningful TOTAL SALES: VOLUME, PRICE, EXCHANGE
1Q `03 % CHG. VOL PX FX -------------------------------------------------------------------------------------------------------------------- TOTAL SALES $13,388 10% 1 7 2 ------- -- - - - Total Pharmaceutical Sales 5,717 18% 11 2 5 ----- -- -- - - U.S. 3,588 14% 11 3 0 Foreign 2,129 23% 11 -1 13 Other Medco Sales 7,671 5%
MERCK & CO., INC. OTHER FINANCIAL DISCLOSURES FIRST QUARTER 2003 OTHER (INCOME)/EXPENSE, NET
1Q `03 1Q `02 ------- ------- INTEREST INCOME $ (88.3) $ (98.4) INTEREST EXPENSE 95.3 95.3 EXCHANGE (GAINS)/LOSSES (7.1) (2.7) MINORITY INTERESTS 51.8 50.7 AMORTIZATION OF INTANGIBLES 54.8 51.4 Other, net (47.3) (52.5) ------- ------- TOTAL $ 59.2 $ 43.8
JOINT VENTURE SALES DETAIL All sales reported here are end-market JV sales, presented on a "NET" basis.
MERIAL 1Q `03 1Q `02 ---- ---- IVOMEC, HEARTGARD, other avermectins $ 97 $ 99 FRONTLINE 133 119 Biologicals 102 87 Other Animal Health 46 46 Poultry Genetics 54 52 ---- ---- TOTAL MERIAL SALES $432 $403
AVENTIS PASTEUR-MSD 1Q `03 1Q `02 ---- ---- HEPATITIS VACCINES $ 19 $ 14 VIRAL VACCINES 11 7 Other Vaccines 90 69 ---- ---- TOTAL AP-MSD SALES $120 $ 90
MERCK / SCHERING-PLOUGH COLLABORATION 1Q `03 1Q `02 ---- --- Zetia (Worldwide) $ 46 $ - TOTAL $ 46 $ -
TOTAL MEDCO PRESCRIPTION/CLAIMS VOLUME (IN MILLIONS)
2003 MAIL RETAIL TOTAL -- --- --- FIRST QUARTER 20 113 133 SECOND QUARTER 0 0 0 THIRD QUARTER 0 0 0 FOURTH QUARTER 0 0 0 -- --- --- YEAR TO DATE 20 113 133
2002 MAIL RETAIL TOTAL -- --- --- FIRST QUARTER 20 121 141 SECOND QUARTER 21 119 140 THIRD QUARTER 20 110 130 FOURTH QUARTER 21 117 138 -- --- --- YEAR TO DATE 82 467 548